Valens GroWorks Corp (CSE:VGW, OTCQB:VGWCF) is inviting investors to join them on Wednesday, May 15, 2019, from 12-1 PM PT / 3-4 PM ET for a webinar covering “The Future of Cannabis in Canada” report. Valens sponsored the report which was released in early April. Valens and its partner Resonance Consultancy teamed up with Insights West to provide investors with an overview of the Canadian cannabis market from a consumer and bystander perspective. The report also covers future trends in the market.
The webinar will be hosted by Valens Business and Marketing Manager Kayla Mann. Joining her as panelists are Valens Executive VP of Strategy and Investments Everette Knight and Resonance Consultancy President and CEO Chris Fair. The following topics will be covered in the webinar:
- Cannabis in Canada – Culture, Consumers and its Future
- Canada’s Pot of Gold
- Legal Recreational Cannabis State of the Nation
- Who is the Canadian Cannabis Consumer?
- How Do Canadians Consume Cannabis?
- Marketing Pot-Ential
- Sales and Distribution Preferences
To join the webinar on Wednesday, click here.
To view The Future of Cannabis in Canada report, click here.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).